Novartis Faces Generic Challenge To Heart Drug Patent
Generics drugmaker Stada has asked a London judge to clear the way for it to launch a generic version of Novartis' blockbuster heart failure treatment called Entresto by nixing several of...To view the full article, register now.
Already a subscriber? Click here to view full article